Obstetrics, gynecology and reproductive medicine guidelines

Neonatology

PubMed Free Full Text

Patent ductus arteriosus

International

• Cochrane Library
  • Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants
  • Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants
  • Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants
  • Indomethacin for asymptomatic patent ductus arteriosus in preterm infants
  • Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants
  • Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants
  • Furosemide for prevention of morbidity in indomethacin-treated infants with patent ductus arteriosus
  • Dopamine versus no treatment to prevent renal dysfunction in indomethacin-treated preterm newborn infants
  • Continuous infusion versus intermittent bolus doses of indomethacin for patent ductus arteriosus closure in symptomatic preterm infants

New Zealand

• Auckland District Health Board
  • Patent Ductus Arteriosus [2007]

United Kingdom

• National Institute for Health and Clinical Excellence
  • Endovascular closure of patent ductus arteriosus [2004]

United States of America

• University of Michigan Evidence-Based Pediatrics
  • Indomethacin Prohylaxis in VLBW Infants Does Not Reduce Mortality or Survival Without Neurosensory Impairment [2002]

{Related topics}

• Guidelines
  • Neonatal cardiovascular diseases